Works matching IS 03065251 AND DT 2000 AND VI 49 AND IP 3
1
- British Journal of Clinical Pharmacology, 2000, v. 49, n. 3, p. 286, doi. 10.1046/j.1365-2125.2000.00142-3.x
- Hägg, Staffan;
- Granberg, Kerstin;
- Carleborg, Lena
- Article
2
- British Journal of Clinical Pharmacology, 2000, v. 49, n. 3, p. 285, doi. 10.1046/j.1365-2125.2000.00142-2.x
- Abraham, Benny K.;
- Adithan, C.;
- Shashindran, C.H.;
- Vasu, S.;
- Alekutty, N.A.
- Article
3
- British Journal of Clinical Pharmacology, 2000, v. 49, n. 3, p. 283, doi. 10.1046/j.1365-2125.2000.00142.x
- Article
4
- British Journal of Clinical Pharmacology, 2000, v. 49, n. 3, p. 279, doi. 10.1046/j.1365-2125.2000.00139.x
- Corey, Alfred E.;
- Agnew, Jeffrey R.;
- Valentine, Suzanne W.;
- Nesbitt, John D.;
- Wagner, Dan L.;
- Powell, James H.;
- Thompson, Gary A.
- Article
5
- British Journal of Clinical Pharmacology, 2000, v. 49, n. 3, p. 274, doi. 10.1046/j.1365-2125.2000.00138.x
- Lapatto-Reiniluoto, O.;
- Kivistö, K.T.;
- Neuvonen, P.J.
- Article
6
- British Journal of Clinical Pharmacology, 2000, v. 49, n. 3, p. 269, doi. 10.1046/j.1365-2125.2000.00137.x
- Curtis, S.P.;
- Eardley, I.;
- Boyce, M.;
- Larson, P.;
- Haesen, R.;
- Gottesdiener, K.;
- Gertz, B.J.
- Article
7
- British Journal of Clinical Pharmacology, 2000, v. 49, n. 3, p. 264, doi. 10.1046/j.1365-2125.2000.00127.x
- Sorensen, Henrik Toft;
- Nielsen, Gunnar Lauge;
- Christensen, Kaare;
- Tage-Jensen, Ulrik;
- Ekbom, Anders;
- Baron, John
- Article
8
- British Journal of Clinical Pharmacology, 2000, v. 49, n. 3, p. 254, doi. 10.1046/j.1365-2125.2000.00166.x
- Fijn, R.;
- Engels, S.A.G.;
- Brouwers, J.R.B.J.;
- Knaap, R.J.;
- De Jong-Van den Berg, L.T.W.
- Article
9
- British Journal of Clinical Pharmacology, 2000, v. 49, n. 3, p. 244, doi. 10.1046/j.1365-2125.2000.00134.x
- Ohyama, K.;
- Nakajima, M.;
- Suzuki, M.;
- Shimada, N.;
- Yamazaki, H.;
- Yokoi, T.
- Article
10
- British Journal of Clinical Pharmacology, 2000, v. 49, n. 3, p. 240, doi. 10.1046/j.1365-2125.2000.00130.x
- Welfare, Mark R.;
- Bassendine, Margaret F.;
- Daly, Ann K.
- Article
11
- British Journal of Clinical Pharmacology, 2000, v. 49, n. 3, p. 231, doi. 10.1046/j.1365-2125.2000.049003231.x
- Wittke, Bärbel;
- Ensor, Hilary;
- Jain Chung;
- Birnböck, Herbert;
- Lausecker, Berthold;
- Ertel, Sylvie I.;
- Mackie, Ian J.;
- Machin, Samuel J.
- Article
12
- British Journal of Clinical Pharmacology, 2000, v. 49, n. 3, p. 223, doi. 10.1046/j.1365-2125.2000.00162.x
- Davis, Timothy M.E.;
- Daly, Frank;
- Walsh, John P.;
- Ilett, Kenneth F.;
- Beilby, John P.;
- Dusci, Leon J.;
- Hugh, P.;
- Barrett, R.
- Article
13
- British Journal of Clinical Pharmacology, 2000, v. 49, n. 3, p. 215, doi. 10.1046/j.1365-2125.2000.00135.x
- Mitchell, D.Y.;
- St. Peter, J.V.;
- Eusebio, R.A.;
- Pallone, K.A.;
- Kelly, S.C.;
- Russell, D.A.;
- Nesbitt, J.D.;
- Thompson, G.A.;
- Powell, J.H.
- Article
14
- British Journal of Clinical Pharmacology, 2000, v. 49, n. 3, p. 207, doi. 10.1046/j.1365-2125.2000.00141.x
- Stuart-Harris, R.;
- Joel, S.P.;
- McDonald, P.;
- Currow, D.;
- Slevin, M.L.
- Article
15
- British Journal of Clinical Pharmacology, 2000, v. 49, n. 3, p. 199, doi. 10.1046/j.1365-2125.2000.00143.x
- Rosenborg, Johan;
- Larsson, Per;
- Nyberg, Lars
- Article
16
- British Journal of Clinical Pharmacology, 2000, v. 49, n. 3, p. 185, doi. 10.1046/j.1365-2125.2000.00159.x
- Article